Loading…

Renal Prognosis in Children With Tubulointerstitial Nephritis and Uveitis Syndrome

Tubulointerstitial nephritis (TIN) and uveitis (TINU) syndrome is a rare disease. The renal prognosis is generally thought to be better in children with TINU syndrome than in adults. However, data are scarce. We aimed to investigate the long-term renal prognosis in a French cohort of children with T...

Full description

Saved in:
Bibliographic Details
Published in:Kidney international reports 2021-12, Vol.6 (12), p.3045-3053
Main Authors: Chevalier, Agnès, Duflos, Claire, Clave, Stephanie, Boyer, Olivia, Hogan, Julien, Lahoche, Annie, Decramer, Stephane, Broux, Françoise, Vrillon, Isabelle, Allain-Launay, Emma, Bacchetta, Justine, Tanne, Corentin, Allard, Lise, Cloarec, Sylvie, Pietrement, Christine, Bourdat-Michel, Guylhene, Djeddi, Djamal, Dunand, Olivier, Faudeux, Camille, Nobili, François, Taque, Sophie, Ulinski, Tim, Zaloszyc, Ariane, Morin, Denis, Fila, Marc
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Tubulointerstitial nephritis (TIN) and uveitis (TINU) syndrome is a rare disease. The renal prognosis is generally thought to be better in children with TINU syndrome than in adults. However, data are scarce. We aimed to investigate the long-term renal prognosis in a French cohort of children with TINU syndrome. We performed a national retrospective study including 23 French pediatric nephrology centers enrolling patients with TINU syndrome diagnosed between January 2000 and December 2018. A total of 46 patients were included (52% female, median age 13.8 years). At diagnosis of TIN, the median estimated glomerular filtration rate (eGFR) was 30.6 ml/min per 1.73 m2 (4.9–62.8). The median time between diagnosis of uveitis and TIN was 0.4 months (−4.1; +17.1). All patients had anterior uveitis, but 12 (29%) were asymptomatic. Nearly all patients (44 of 46) received steroid treatment, and 12 patients (26%) received a second-line therapy. At last follow-up (median 2.8 years), the median eGFR was 87.5 ml/min per 1.73 m2 (60.3–152.7) and 
ISSN:2468-0249
2468-0249
DOI:10.1016/j.ekir.2021.09.017